HomePANACEABIO • NSE
add
Panacea Biotec Ltd
Previous close
₹422.95
Day range
₹410.05 - ₹430.00
Year range
₹112.35 - ₹430.00
Market cap
25.45B INR
Avg Volume
142.90K
P/E ratio
-
Dividend yield
-
Primary exchange
NSE
Market news
Financials
Income Statement
Revenue
Net income
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | 1.47B | 3.03% |
Operating expense | 1.06B | 12.04% |
Net income | 48.00M | 157.90% |
Net profit margin | 3.26 | 156.21% |
Earnings per share | — | — |
EBITDA | 70.25M | 2,967.35% |
Effective tax rate | 1.05% | — |
Balance Sheet
Total assets
Total liabilities
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.77B | -3.52% |
Total assets | 12.43B | -2.29% |
Total liabilities | 4.14B | -3.42% |
Total equity | 8.29B | — |
Shares outstanding | 62.34M | — |
Price to book | 3.17 | — |
Return on assets | — | — |
Return on capital | -0.49% | — |
Cash Flow
Net change in cash
| (INR) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | 48.00M | 157.90% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Panacea Biotec is a global generic and specialty pharmaceutical and vaccine maker. It has principal offices in New Delhi, Mumbai, and Lalru. It has business interests in research, development, manufacturing and marketing of pharmaceutical formulations, vaccines, biosimilars, and natural products. Wikipedia
Founded
1984
Website
Employees
1,936
